Ozaki Makoto, Shimotsuma Motoshi, Kuranaga Takefumi, Kakeya Hideaki, Hirose Tsunehisa
Research and Development Department, Purification Section, Nacalai Tesque, Inc., Ishibashi Kaide-cho, Muko-shi, Kyoto 617-0004, Japan.
Department of System Chemotherapy and Molecular Sciences, Division of Medicinal Frontier Sciences, Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida, Kyoto 606-8501, Japan.
Analyst. 2023 Mar 13;148(6):1209-1213. doi: 10.1039/d2an01885c.
We developed a system to separate and identify racemised and isomerised aspartic acid (Asp) residues in amyloid β (Aβ) by labeling with an original chiral resolution labeling reagent, 1-fluoro-2,4-dinitrophenyl-5-D-leucine-,-dimethylethylenediamine-amide (D-FDLDA). The racemised and isomerised Asp residues labeled with D-FDLDA in Aβ fragments generated by digesting with trypsin and endoproteinase Glu-C were separated and identified by liquid chromatography-mass spectrometry (LC-MS) under simple gradient conditions. Furthermore, the labeled Aβ fragments did not aggregate and remained stable at least for 1 week at 4 °C.
我们开发了一种系统,通过用一种原创的手性拆分标记试剂1-氟-2,4-二硝基苯基-5-D-亮氨酸-N,N'-二甲基乙二胺酰胺(D-FDLDA)进行标记,来分离和鉴定淀粉样β蛋白(Aβ)中消旋化和异构化的天冬氨酸(Asp)残基。用胰蛋白酶和谷氨酸内肽酶Glu-C消化产生的Aβ片段中,用D-FDLDA标记的消旋化和异构化Asp残基,在简单梯度条件下通过液相色谱-质谱联用(LC-MS)进行分离和鉴定。此外,标记后的Aβ片段不会聚集,并且在4℃下至少能稳定保存1周。